benzothiazoline has been researched along with Acute Promyelocytic Leukemia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bian, J; Cheng, Y; Chu, Y; Gao, Y; He, J; Li, Y; Lin, X; Min, Z; Peng, C; Ye, D; Zhang, P | 1 |
1 other study(ies) available for benzothiazoline and Acute Promyelocytic Leukemia
| Article | Year |
|---|---|
Discovery of Novel Benzothiazepinones as Irreversible Covalent Glycogen Synthase Kinase 3β Inhibitors for the Treatment of Acute Promyelocytic Leukemia.
Topics: Animals; Apoptosis; Benzothiazoles; Cell Line, Tumor; Cell Proliferation; Female; Glycogen Synthase Kinase 3 beta; Half-Life; Humans; Isoenzymes; Kinetics; Leukemia, Promyelocytic, Acute; Male; Mice; Mice, Inbred ICR; Mice, Nude; Protein Kinase Inhibitors; Structure-Activity Relationship; Xenograft Model Antitumor Assays | 2021 |